332 related articles for article (PubMed ID: 33328329)
1.
Lananna BV; McKee CA; King MW; Del-Aguila JL; Dimitry JM; Farias FHG; Nadarajah CJ; Xiong DD; Guo C; Cammack AJ; Elias JA; Zhang J; Cruchaga C; Musiek ES
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328329
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice.
Zeng X; Cheung SKK; Shi M; Or PMY; Li Z; Liu JYH; Ho WLH; Liu T; Lu K; Rudd JA; Wang Y; Chan AM
J Neuroinflammation; 2023 Dec; 20(1):290. PubMed ID: 38042775
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden.
McKee CA; Lee J; Cai Y; Saito T; Saido T; Musiek ES
Sci Rep; 2022 Feb; 12(1):1796. PubMed ID: 35110643
[TBL] [Abstract][Full Text] [Related]
4. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
Deming Y; Black K; Carrell D; Cai Y; Del-Aguila JL; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Bertelsen S; Huang KL; Sutphen CL; Tarawneh R; Fagan AM; Holtzman DM; Morris JC; Goate AM; Dougherty JD; Cruchaga C
BMC Neurol; 2016 Nov; 16(1):217. PubMed ID: 27832767
[TBL] [Abstract][Full Text] [Related]
5. Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.
Connolly K; Lehoux M; O'Rourke R; Assetta B; Erdemir GA; Elias JA; Lee CG; Huang YA
Alzheimers Dement; 2023 Jan; 19(1):9-24. PubMed ID: 35234337
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Amyloid-β (Aβ)-Induced Cognitive Impairment and Neuroinflammation in CHI3L1 Knockout Mice through Downregulation of ERK-PTX3 Pathway.
Ham HJ; Lee YS; Koo JK; Yun J; Son DJ; Han SB; Hong JT
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791588
[TBL] [Abstract][Full Text] [Related]
8. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease.
Moreno-Rodriguez M; Perez SE; Nadeem M; Malek-Ahmadi M; Mufson EJ
J Neuroinflammation; 2020 Feb; 17(1):58. PubMed ID: 32066474
[TBL] [Abstract][Full Text] [Related]
9. Sex difference in CHI3L1 expression levels in human brain aging and in Alzheimer's disease.
Sanfilippo C; Castrogiovanni P; Imbesi R; Kazakowa M; Musumeci G; Blennow K; Zetterberg H; Di Rosa M
Brain Res; 2019 Oct; 1720():146305. PubMed ID: 31247206
[TBL] [Abstract][Full Text] [Related]
10. Sex-dependent neuro-deconvolution analysis of Alzheimer's disease brain transcriptomes according to CHI3L1 expression levels.
Sanfilippo C; Castrogiovanni P; Imbesi R; Musumeci G; Vecchio M; Li Volti G; Tibullo D; Broggi G; Caltabiano R; Ulivieri M; Kazakova M; Parenti R; Vicario N; Fazio F; Di Rosa M
J Neuroimmunol; 2022 Dec; 373():577977. PubMed ID: 36228382
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.
Jung YY; Kim KC; Park MH; Seo Y; Park H; Park MH; Chang J; Hwang DY; Han SB; Kim S; Son DJ; Hong JT
Theranostics; 2018; 8(3):749-766. PubMed ID: 29344304
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer's Disease Model.
Kim E; Nohara K; Wirianto M; Escobedo G; Lim JY; Morales R; Yoo SH; Chen Z
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356628
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.
Querol-Vilaseca M; Colom-Cadena M; Pegueroles J; San Martín-Paniello C; Clarimon J; Belbin O; Fortea J; Lleó A
J Neuroinflammation; 2017 Jun; 14(1):118. PubMed ID: 28599675
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
[TBL] [Abstract][Full Text] [Related]
15. Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genes.
Ma Z; Jiang W; Zhang EE
Sci Rep; 2016 Oct; 6():36035. PubMed ID: 27796320
[TBL] [Abstract][Full Text] [Related]
16. The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.
Furtado A; Astaburuaga R; Costa A; Duarte AC; Gonçalves I; Cipolla-Neto J; Lemos MC; Carro E; Relógio A; Santos CRA; Quintela T
J Alzheimers Dis; 2020; 77(2):795-806. PubMed ID: 32741824
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease.
Sanchez-Mico MV; Jimenez S; Gomez-Arboledas A; Muñoz-Castro C; Romero-Molina C; Navarro V; Sanchez-Mejias E; Nuñez-Diaz C; Sanchez-Varo R; Galea E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Glia; 2021 Apr; 69(4):997-1011. PubMed ID: 33283891
[TBL] [Abstract][Full Text] [Related]
18. K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression.
Choi JY; Yeo IJ; Kim KC; Choi WR; Jung JK; Han SB; Hong JT
J Neuroinflammation; 2018 Aug; 15(1):224. PubMed ID: 30098604
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
20. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
